INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 48m ago
HOUSE PTR8m ago
SEC 13F8m ago
ROBINHOOD CHAIN7m ago
BJ
Corporate insider

Bluestone Jeffrey

DirectorCIK 0001771814

EDGAR filingsOpen in network
Disclosed transactions18
Buys / sells0 / 7
Max Insider Score35
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
4,665 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    GILEAD SCIENCES, INC.Director · Dec 1, 2025
8
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL
$167K
1,165 sh
Aug 20, 2026
Aug 21, 2026
traded Aug 20, 2026
+1d
SEC FORM 4

Evidence

11
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$263K
1,816 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

8
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$242K
1,658 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$1,754
26 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

1
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$3,805
26 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$21K
335 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

1
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$49K
335 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
335 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

2
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$79K
1,165 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

2
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$122K
1,816 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

2
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$112K
1,658 sh
Aug 20, 2026Aug 21, 2026
traded Aug 20, 2026
+1dSEC FORM 4

Evidence

13
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$337K
5,000 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC FORM 4

Evidence

25
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$618K
5,000 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC FORM 4

Evidence

0
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
5,000 sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC FORM 4

Evidence

27
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise
M$325K
5,000 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC FORM 4

Evidence

21
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Option exercise
M—
5,000 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC FORM 4

Evidence

35
BJ
Bluestone JeffreyDirector
GILDGILEAD SCIENCES, INC.
Open-market sale
SELL$625K
5,000 sh
Nov 28, 2025Dec 1, 2025
traded Nov 28, 2025
+3dSEC FORM 4

Evidence